Therapeutic potential of the FPR2/ALX agonist AT-01-KG in the resolution of articular inflammation-Reference-Cited by-同舟云学术

Therapeutic potential of the FPR2/ALX agonist AT-01-KG in the resolution of articular inflammation

Published:2021-03 Issue: Volume:165 Page:105445
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Galvão Izabela,Melo Eliza M.,de Oliveira Vivian L.S.^ORCID,Vago Juliana P.^ORCID,Queiroz-Junior Celso,de Gaetano Monica,Brennan Eoin^ORCID,Gahan Kevin,Guiry Patrick J.,Godson Catherine,Teixeira Mauro M.^ORCID

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Elsevier BV

Subject

Pharmacology

Reference55 articles.

1. Origin and physiological roles of inflammation;Medzhitov;Nature,2008

2. Nonresolving inflammation;Nathan;Cell,2010

3. Primary Osteoarthritis;Aboulenain,2020

4. Gout or’ pseudogout’: how to differentiate crystal-induced arthropathies;Joseph;Geriatrics,1995

5. Molecular diagnostic and pathogenesis of hereditary hemochromatosis;Santos;Int. J. Mol. Sci.,2012

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment with lipoxin A4 improves influenza A infection outcome, induces macrophage reprogramming, anti-inflammatory and pro-resolutive responses;Inflammation Research;2024-08-30

2. GPCRs overexpression and impaired fMLP-induced functions in neutrophils from chronic kidney disease patients;Frontiers in Immunology;2024-08-26

3. Clearing the Path: Exploring Apoptotic Cell Clearance in Inflammatory and Autoimmune Disorders for Therapeutic Advancements;Molecular Biotechnology;2024-06-27

4. Treatment with lipoxin A 4 improves influenza A infection outcome through macrophage reprogramming, anti-inflammatory and pro-resolutive responses;2024-06-13

5. Efferocytosis: Current status and future prospects in the treatment of autoimmune diseases;Heliyon;2024-04